1. Home
  2. MDXH vs PVBC Comparison

MDXH vs PVBC Comparison

Compare MDXH & PVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • PVBC
  • Stock Information
  • Founded
  • MDXH 2003
  • PVBC 1913
  • Country
  • MDXH Belgium
  • PVBC United States
  • Employees
  • MDXH N/A
  • PVBC N/A
  • Industry
  • MDXH
  • PVBC Major Banks
  • Sector
  • MDXH
  • PVBC Finance
  • Exchange
  • MDXH Nasdaq
  • PVBC Nasdaq
  • Market Cap
  • MDXH 203.4M
  • PVBC 224.8M
  • IPO Year
  • MDXH 2021
  • PVBC 2015
  • Fundamental
  • Price
  • MDXH $4.92
  • PVBC $12.75
  • Analyst Decision
  • MDXH Buy
  • PVBC Hold
  • Analyst Count
  • MDXH 1
  • PVBC 1
  • Target Price
  • MDXH $6.00
  • PVBC $12.50
  • AVG Volume (30 Days)
  • MDXH 274.6K
  • PVBC 41.6K
  • Earning Date
  • MDXH 11-12-2025
  • PVBC 10-23-2025
  • Dividend Yield
  • MDXH N/A
  • PVBC N/A
  • EPS Growth
  • MDXH N/A
  • PVBC 131.87
  • EPS
  • MDXH N/A
  • PVBC 0.74
  • Revenue
  • MDXH $98,953,000.00
  • PVBC $62,100,000.00
  • Revenue This Year
  • MDXH $24.43
  • PVBC $9.73
  • Revenue Next Year
  • MDXH $21.00
  • PVBC $4.87
  • P/E Ratio
  • MDXH N/A
  • PVBC $17.27
  • Revenue Growth
  • MDXH 22.56
  • PVBC 12.27
  • 52 Week Low
  • MDXH $1.35
  • PVBC $10.27
  • 52 Week High
  • MDXH $5.33
  • PVBC $13.02
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 64.64
  • PVBC 56.78
  • Support Level
  • MDXH $4.71
  • PVBC $12.61
  • Resistance Level
  • MDXH $5.33
  • PVBC $12.82
  • Average True Range (ATR)
  • MDXH 0.30
  • PVBC 0.19
  • MACD
  • MDXH 0.05
  • PVBC 0.02
  • Stochastic Oscillator
  • MDXH 72.11
  • PVBC 70.31

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About PVBC Provident Bancorp Inc. (MD)

Provident Bancorp Inc provides a range of banking products and services to small and medium-sized commercial customers. It attracts deposits from the general public and uses those funds to originate loans, commercial real estate, construction and land, and commercial business loans, and to invest in securities. The company lending activities include providing commercial real estate loans, multi-family residential real estate loans, commercial business loans, construction and land development loans, one-to four-family residential loans, home equity loans & lines of credit, and consumer loans.

Share on Social Networks: